Pricing Log in Create free account

Aspira Women's Health Inc. (AWHL) vs DermTech, Inc. (DMTKQ)

Aspira Women's Health Inc. and DermTech, Inc. are both Diagnostics & Research companies. DermTech, Inc. is the larger, with a market value of $3.3M against $2.4M — 1.3× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −8.00%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −572.2%) and the higher return on invested capital (0.00% vs −5,493.5%). Across the 16 metrics below, Aspira Women's Health Inc. leads on 9 and DermTech, Inc. on 7.

Valuation

Metric AWHL DMTKQ Diagnostics & Research median
P/E n/m n/m 35.56
P/S 1.19 n/m 4.37
P/B n/m n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 0.45 24.35
EV/Sales 1.36 (2.49) 5.51
Earnings yield (106.09%) 0.00% (1.89%)
Free cash flow yield (46.46%) 0.00% (0.15%)

Profitability

Metric AWHL DMTKQ Diagnostics & Research median
Gross margin 58.78% 8.51% 50.89%
Operating margin (80.75%) (588.62%) (8.57%)
Net margin (117.07%) (572.19%) (6.37%)
Free cash flow margin (55.32%) (460.10%) 0.00%
Return on equity 201.29% (121.75%) (2.92%)
Return on assets (213.58%) (64.00%) (6.71%)
Return on invested capital 0.00% (5,493.45%) 0.00%

Growth

Metric AWHL DMTKQ Diagnostics & Research median
Revenue growth (TTM) (8.00%) 9.71% 7.69%
EPS growth (last fiscal year) 60.22% 20.36% 25.92%
Revenue growth, 5-year CAGR 14.66% 44.33% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL DMTKQ Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 3.53 2.02
Net debt to EBITDA 0.00 0.57 0.70

Dividend

Metric AWHL DMTKQ Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric AWHL DMTKQ Diagnostics & Research median
Market cap 2.44m 3.29m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack